Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 known ✓ | O15379 | 1/20 | 0.52 |
| ▸ | HDAC6 known ✓ | Q9UBN7 | 1/20 | 0.52 |
| ▸ | MAPK14 known ✓ | Q16539 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.56 |
| ▸ | ATM | Q13315 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.52 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.52 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL203283 | 0.98 | ALDH1A1 (0.61) | ALDH1A1SRD5A2ATML3MBTL1TDP1 | |
| Trimethylammonium SCHEMBL27729915 | 0.93 | HPGD (0.55) | ALDH1A1SRD5A2ATML3MBTL1TDP1 | |
| Hydrochloric Acid SCHEMBL8833446 | 0.91 | HDAC3 (0.59) | ALDH1A1SRD5A2LOXL2HDAC3HDAC6 | |
| Acrylic Acid SCHEMBL29144363 | 0.89 | ALDH1A1 (0.47) | ALDH1A1SRD5A2ATML3MBTL1TDP1 | |
| Acrylic Acid SCHEMBL29144364 | 0.89 | ALDH1A1 (0.47) | ALDH1A1SRD5A2ATML3MBTL1TDP1 | |
| SCHEMBL7150384 | 0.89 | HDAC3 (0.61) | ALDH1A1SRD5A2LOXL2HDAC3HDAC6 | |
| Ethyl Chloride SCHEMBL29011196 | 0.89 | ALDH1A1 (0.50) | ALDH1A1SRD5A2ATML3MBTL1TDP1 | |
| SCHEMBL27536563 | 0.87 | ALDH1A1 (0.49) | ALDH1A1SRD5A2ATML3MBTL1TDP1 | |
| SCHEMBL13885490 | 0.85 | CES2 (0.65) | ALDH1A1L3MBTL1LOXL2HDAC3HDAC6 | |
| SCHEMBL2900640 | 0.84 | ATM (0.63) | ALDH1A1SRD5A2ATML3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12440607-B2 | Multifunctional crosslinkers: compounds, compositions, and products thereof | BIOCOAT, INCORPORATED (US) | 2025-10-14 | — | — | US | claimed |
| CN-118119593-A | Multifunctional crosslinking agent: compounds, compositions and products thereof | 生物涂层有限公司 | 2024-05-31 | — | — | CN | claimed |
| EP-4370498-A1 | MULTIFUNCTIONAL CROSSLINKERS: COMPOUNDS, COMPOSITIONS, AND PRODUCTS THEREOF | Biocoat, Incorporated (US) | 2024-05-22 | — | — | EP | claimed |
| US-20230027324-A1 | Multifunctional Crosslinkers: Compounds, Compositions, And Products Thereof | WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2023-01-26 | — | — | US | claimed |
| WO-2023287638-A1 | MULTIFUNCTIONAL CROSSLINKERS: COMPOUNDS, COMPOSITIONS, AND PRODUCTS THEREOF | BIOCOAT, INCORPORATED (US) | 2023-01-19 | — | — | WO | claimed |
| CN-104769022-B | A kind of method for being used to be applied to coating in polymeric substrates | 索菲昂生物科学有限公司 | 2018-06-12 | — | — | CN | claimed |
| EP-2900740-B1 | A METHOD FOR APPLYING A COATING TO A POLYMERIC SUBSTRATE | SOPHION BIOSCIENCE AS (DK) | 2017-08-23 | — | — | EP | claimed |
| US-20150240115-A1 | METHOD FOR APPLYING A COATING TO A POLYMERIC SUBSTRATE | THE TECHNICAL UNIVERSITY OF DENMARK (DK) | 2015-08-27 | — | — | US | claimed |
| EP-2900740-A1 | A METHOD FOR APPLYING A COATING TO A POLYMERIC SUBSTRATE | Sophion Bioscience A/S (DK) | 2015-08-05 | — | — | EP | claimed |
| CN-104769022-A | A method for applying a coating to a polymeric substrate | SOPHION BIOSCIENCE AS | 2015-07-08 | — | — | CN | claimed |
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | disclosed |
| US-20260000813-A1 | Multifunctional Crosslinkers: Compounds, Compositions, And Products Thereof | BIOCOAT INCORPORATED (US) | 2026-01-01 | — | — | US | disclosed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | disclosed |
| EP-4584243-B1 | CROSSLINKERS | HEMOTEQ AG (DE) | 2025-11-05 | — | — | EP | disclosed |
| US-12440607-B2 | Multifunctional crosslinkers: compounds, compositions, and products thereof | BIOCOAT, INCORPORATED (US) | 2025-10-14 | — | — | US | disclosed |
| US-20150240115-A1 | METHOD FOR APPLYING A COATING TO A POLYMERIC SUBSTRATE | THE TECHNICAL UNIVERSITY OF DENMARK (DK) | 2015-08-27 | — | — | US | disclosed |
| EP-2900740-A1 | A METHOD FOR APPLYING A COATING TO A POLYMERIC SUBSTRATE | Sophion Bioscience A/S (DK) | 2015-08-05 | — | — | EP | disclosed |
| CN-104769022-A | A method for applying a coating to a polymeric substrate | SOPHION BIOSCIENCE AS | 2015-07-08 | — | — | CN | disclosed |
| US-20130012623-A1 | METHODS AND MANUFACTURES RELATED TO ENCAPSULATION OF SILICA AEROGEL POWDER | AEONCLAD COATINGS, LLC. (US) | 2013-01-10 | — | — | US | disclosed |
| WO-2011119745-A2 | METHODS AND MANUFACTURES RELATED TO ENCAPSULATION OF SILICA AEROGEL POWDER | AEONCLAD COATINGS, LLC. (US) | 2011-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000813-A1 | Multifunctional Crosslinkers: Compounds, Compositions, And Products Thereof | WIZ, CDH1, TET1 | HDAC3 3279/4885HDAC6 1836/4885MAPK14 1756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.